Patients with CD44+ tumors (defined by dichotomization at intensity >weak or by >26% positive cells), presented significantly more often with larger, higher differentiated tumors, but no significant differences were observed in tumor localization (tonsil or tongue base), stage, or age between patients with CD44+ and CD44− tumors (data not shown). Here, CD44 is linked to neoplasm.